bms-986012
mAbexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Oct 30, 2014 (NCT02247349)
Timeline
Indications
Studied for
Mechanism of action
- Fucosyl-GM1BINDING AGENT
Fucosyl-GM1 binding agent
- Fucosyl-GM1INHIBITOR
Fucosyl-GM1 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297704 ↗
Also known as
- bms-986012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06646276 | Phase 3 | Jan 31, 2025 | Bristol-Myers Squibb |
| NCT04702880 | Phase 2 | Mar 17, 2021 | Bristol-Myers Squibb |
| NCT02949895 | Phase 1 | Nov 29, 2016 | Bristol-Myers Squibb |
| NCT02815592 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2016 | Bristol-Myers Squibb |
| NCT02247349 | Phase 1/Phase 2 (Phase 2) | Oct 30, 2014 | Bristol-Myers Squibb |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 5 | 5 | 3 | 2014 |
1 organizations
Page 1 / 1